Meningococcal vaccine group A polysaccharide - Wuhan Institute of Biological Products
Latest Information Update: 08 Dec 2015
At a glance
- Originator Wuhan Institute of Biological Products
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Meningococcal group A infections